perampanel (Q868658)

Perampanel (English)

3 October 2016

C₂₃H₁₅N₃O

1 reference

Perampanel (English)

19 November 2016

C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4

1 reference

https://www.whocc.no/atc_ddd_index/?code=N03AX22

Perampanel (English)

19 November 2016

8 milligram

route of administration

oral administration

1 reference

reference URL

1 reference

14 February 2018

World Health Organisation international non-proprietary name

perampanel (English)

1 reference

perampanel (English)

medical condition treated

3 October 2016

epilepsy

1 reference

Drug Indications Extracted from FAERS

2 October 2018

22 October 2012

Food and Drug Administration

1 reference

Inxight: Drugs Database

https://drugs.ncats.io/drug/H821664NPK

2 November 2018

reference URL

http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/202834s005lbl.pdf

significant drug interaction

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sodium oxybate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

legal status (medicine)

boxed warning

1 reference

reference URL

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

imported from Wikimedia project

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (English)

pregnancy category

US pregnancy category C

1 reference

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Perampanel

last update

4 May 2016

Commons category

Perampanel

0 references

Identifiers

InChI

InChI=1S/C23H15N3O/c24-15-17-8-4-5-11-20(17)21-14-18(22-12-6-7-13-25-22)16-26(23(21)27)19-9-2-1-3-10-19/h1-14,16H

1 reference

Perampanel (English)

19 November 2016

2 references

Perampanel (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

380917-97-5

2 references

perampanel (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=380917-97-5

9 April 2021

1 reference

Perampanel (English)

19 November 2016

2 references

Perampanel (English)

19 November 2016

Reaxys registry number

11343244

1 reference

perampanel (English)

3 October 2016

mapping relation type

2 references

PERAMPANEL (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C23H15N3O/c24-15-17-8-4-5-11-20(17)21-14-18(22-12-6-7-13-25-22)16-26(23(21)27)19-9-2-1-3-10-19/h1-14,16H

1 reference

PERAMPANEL (English)

19 November 2016

2 references

inferred from InChIKey

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

1 reference

2 references

DSSTOX compound identifier

0 references

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.219.846

27 December 2018

ECHA Substance Infocard ID

2-[2-oxo-1-phenyl-5-(pyridin-2-yl)-1,2-dihydropyridin-3-yl]benzonitrile (English)

quotation

CAS no.: 380917-97-5 (English)

100.219.846

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.219.846

27 December 2018

2-[2-oxo-1-phenyl-5-(pyridin-2-yl)-1,2-dihydropyridin-3-yl]benzonitrile (English)

quotation

CAS no.: 380917-97-5 (English)

1 reference

Guide to Pharmacology Ligand ID

Perampanel (English)

publication date

17 November 2015

7050

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7050

perampanel (English)

19 November 2016

perampanel

0 references

RxNorm ID

1356552

1 reference

perampanel (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0256305

2 references

based on heuristic

inferred from InChIKey

2 references

perampanel (English)

19 November 2016

MedlinePlus drug identifier

0 references

1 reference

perampanel (English)

19 November 2016

0 references

1 reference

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

perampanel (English)

3 October 2016

0 references

0 references

Microsoft Academic ID

0 references

1 reference

26 January 2022

UMLS CUI

C2698764

1 reference